This alteration in Cldn1 localization may be indicative of its functional switch from a structural tight junction protein to a participant in tumor-promoting processes such as EMT, which is consistent with the findings of previous studies showing the involvement of claudin proteins in cancer progression [17,40,41]. The gene discussed is CLDN1; the disease is cancer.